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Abstract
The current COVID-19 pandemic is a pressing world crisis and people with intellectual disabilities (IDs) are vulnerable due to
disparity in healthcare provision and physical and mental health multimorbidity. While most people will develop mild symp-
toms upon contracting severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), some will develop serious complica-
tions. The aim of this study is to present guidelines for the care and treatment of people with IDs during the COVID-19
pandemic for both community teams providing care to people with IDs and inpatient psychiatric settings. The guidelines cover
specific issues associated with hospital passports, individual COVID-19 care plans, the important role of families and carers,
capacity to make decisions, issues associated with social distancing, ceiling of care/treatment escalation plans, mental health
and challenging behavior, and caring for someone suspected of contracting or who has contracted SARS-CoV-2 within
community or inpatient psychiatric settings. We have proposed that the included conditions recommended by Public Health
England to categorize someone as high risk of severe illness due to COVID-19 should also include mental health and challeng-
ing behavior. There are specific issues associated with providing care to people with IDs and appropriate action must be taken
by care providers to ensure that disparity of healthcare is addressed during the COVID-19 pandemic. We recognize that
our guidance is focused upon healthcare delivery in England and invite others to augment our guidance for use in other
jurisdictions.
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Introduction
Without a doubt, severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), and the development of corona-
virus disease 2019 (COVID-19) is the most pressing current
world crisis. Retrospective cohort studies from patients admit-
ted to hospital who had contracted SARS-CoV-2 and devel-
oped COVID-19 indicated that death was more likely among
those who were older, had diabetes, coronary heart disease,
hypertension, and an elevated sequential organ failure
assessment (SOFA) score or quick SOFA score (Zhou et
al., 2020). Together, there was evidence that having a higher
SOFA score, along with being of an older age, and having ele-
vated fibrin degradation product (D-dimer) at admission sig-
nificantly predicted death (Zhou et al., 2020). Evidence from
other countries has indicated that those who were older, had
cardiovascular disease, diabetes, cancer, or had smoked
tobacco were at increased risk of death (Remuzzi &
Remuzzi, 2020). At the time of writing, the online interactive
dashboard from the Center for Systems Science and Engineer-
ing at Johns Hopkins University reported 5595091 worldwide
are infected with SARS-CoV-2, while 350547 lives have been
lost (Dong, Du, & Gardner, 2020), and the numbers increase
daily. The overall death rate has been reported to be 2.3%
based upon Chinese data (Wu & McGoogan, 2020).
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Although there is some variability across studies, the esti-
mated worldwide prevalence of intellectual disabilities (IDs) is
approximately 1% (Maulik, Mascarenhas, Mathers, Dua, &
Saxena, 2011; McKenzie, Milton, Smith, & Ouellette-
Kuntz, 2016), with higher rates within low- and middle-income
countries, (Maulik et al., 2011) where healthcare systems may
not be as well developed as in the Western world. People with
IDs have an increased rate of mental ill-health (Cooper
et al., 2015; Cooper, Smiley, Morrison, Allan, &
Williamson, 2007; Emerson & Hatton, 2007), and physical
health problems including a wide ranging list of organ-related
disorders (e.g., hypothyroidism, congenital heart problems, diffi-
culties with hearing and vision), specific conditions such as cere-
bral palsy, epilepsy, along with an increased incidence of
pneumonia, as well as other issues such as dysphagia, gastro-
esophageal reflux, and feeding-related problems (Evenhuis,
Henderson, Beange, Lennox, & Chicione, 2000; Haveman
et al., 2010; Krahn, Hammond, & Turner, 2006), leading to an
increased risk of admission to hospital (Dunn, Hughes-McCor-
mack, & Cooper, 2018). Furthermore, lifestyle factors among
people with IDs are known to contribute to disease burden, such
as having a sedentary lifestyle, obesity, and difficulties with
maintaining hygiene independently (Evenhuis et al., 2000;
Haveman et al., 2010; Krahn et al., 2006). Primary care data on
a large sample of people with IDs indicated that this group had
substantial disease comorbidity (Cooper et al., 2015); they were
more likely to have epilepsy, visual impairment, constipation,
hearing loss, Parkinson’s disease, but were less likely to have
coronary heart disease and other-related disorders
(e.g. hypertension), as well as being less likely to have cancer
and chronic obstructive pulmonary disease (COPD; Cooper
et al., 2015). However, it was apparent that comorbidity
increased with age (Cooper et al., 2015).
A systematic review of the causes of death among people
with IDs revealed that mortality rates are substantially higher,
with death coming, on average, 20 years earlier for this popula-
tion (O’Leary, Cooper, & Hughes-McCormack, 2018), and simi-
lar findings have been reported for other countries (McCarron,
Carroll, Kelly, & McCallion, 2015). Conditions associated with
an early death included having profound IDs, epilepsy, difficul-
ties with hearing, vision or mobility, increasing support needs,
being female, and having some specific genetic syndromes. Most
notably, respiratory disease, including pneumonia, was a leading
cause of death in people with IDs, along with circulatory dis-
eases, including heart disease and cardiac failure, cancer and
congenital-related difficulties (O’Leary et al., 2018). Strikingly,
there are studies that have reported that people with IDs have
died from disease, such as aspiration pneumonia, urinary tract
infections, and sepsis which could have been treated through
the provision of good quality equitable healthcare (Glover, Wil-
liams, Heslop, Oyinlola, & Grey, 2017; Heslop et al., 2014;
Hosking et al., 2016; O’Leary et al., 2018; The Learning Disabil-
ity Mortality Review (LeDeR) Programme, 2019). Furthermore,
a number of people with IDs will have difficulties with dyspha-
gia (Robertson, Chadwick, Baines, Emerson, & Hatton, 2017),
and this may in turn increase the risk of aspiration pneumonia.
Prompt and proactive identification of physical health concerns
can be a challenge with people with IDs because of diagnostic
overshadowing (Reiss, Levitan, & Szyszko, 1982), which has an
impact upon the correct recognition of both mental and physi-
cal health problems leading to difficulties with accessing high
quality and appropriate healthcare within primary healthcare
(Beange, McElduff, & Baker, 1995; Nocon, Sayce, &
Nadirshaw, 2008).
The implications for people with IDs during the current
COVID-19 pandemic are clear. There is, without a doubt, likely
to be some apportioning of healthcare within some regions and
people with IDs will be disadvantaged. Rebecca Thomas (2020)
in the Health Service Journal wrote about General Practitioners
(GP) in England sending letters to care providers informing
them that people with IDs will not receive priority medical
treatment in the event of SARS-CoV-2 infection. Prior to this,
the National Institute for Health and Care Excellence
(NICE, 2020a published guidance for the care and treatment of
people who have contracted SARS-CoV-2, recommending use
of the Clinical Frailty Score (Rockwood et al., 2005) within deci-
sion making about access to critical care treatment for compli-
cations arising from SARS-CoV-2 infection, including giving
consideration to the “underlying pathologies, comorbidities, and
severity of acute illness on the likelihood of critical care treat-
ment achieving the desired outcome.” The Clinical Frailty Score
was originally developed for use as an index of frailty among
older people. Individuals are assigned a score from 1 to 7 on a
subjective scale that is meant to measure whether someone is
dependent upon others in order to achieve and carry out tasks
of daily living (Rockwood et al., 2005). Considering that many
people with IDs are dependent upon others to help them carry
out many tasks associated with daily living, and the subsequent
concerns about the validity of the Clinical Frailty Score when
used with this group, NICE (2020b) quickly updated their guid-
ance and stated that this score should not be used with people
who have IDs and/or autism, people with stable long term dis-
abilities, nor younger people, and recommended the use of an
individualized assessment of frailty and needs.
There has also been concern raised about the issuing of do not
attempt resuscitation (DNAR) or cardiopulmonary resuscitation
(DNACPR) orders within England because individuals may have
IDs or autism (British Broadcasting Corporation, 2020). On April
3, 2020, NHS England (2020b) made it clear to hospitals and pri-
mary care providers in England, quoting Professor Stephen Powis,
the National Medical Director of NHS England, who stated that
IDs or Down syndrome “should never be a reason for issuing a
DNACPR order or be used to describe the underlying, or only,
cause of death…learning disabilities are not fatal conditions”.
While responsive changes to the guidance about the care
and treatment of people who have developed COVID-19 in
England are welcomed, this population is likely to present with
a series of healthcare challenges that will require specialist inter-
vention across multiple health and social care systems. Public
Health England (2020d, 2020f) have identified two groups that
are most at risk, and include those at risk of severe illness who
need stringent social distancing (Table 1), and those who are
extremely vulnerable and are at very high risk of severe illness
and require shielding to prevent infection (Table 2). According
to this guidance, many people with IDs should be identified as
being at risk or very high risk of severe illness from COVID-19,
and a general practitioner may have already assigned them to
this category. We recommend that Tables 1 and 2 should be
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used to identify those with IDs at high or very high risk of severe
illness due to SARS-CoV-2 infection, and additional and appro-
priate action should be taken to protect their health and well-
being. We have added three further categories of risk to Table 1
specifically including those with particular physical vulnerabil-
ities, enduring, and severe mental illness and those who display
challenging behavior which may become markedly exacerbated
should they become infected with SARS-CoV-2 and action must
be taken to guard against infection, noting the varying degrees
of risk. However, and paradoxically for some in this group,
stringent social distancing, and shielding may lead to an exacer-
bation of mental health symptoms and/or challenging behavior.
Those with IDs are at higher risk than the general population
from complications arising from contracting SARS-CoV-2, and
the purpose of this article is to present our guidelines for the
care and treatment of people with IDs during the COVID-19
pandemic in an attempt to help address healthcare disparities
within community, residential, and inpatient settings. The
guidelines have been developed collaboratively by a group of
health and social care professionals and carers who care for peo-
ple with IDs, who provide specialist medical, psychiatric, and
social care within both community and inpatient psychiatric set-
tings or in their own homes. Throughout, we have attempted to
focus upon the needs of people with IDs, including those within
this population, who are likely to be at most risk and they are
meant to complement the initial guidance provided by NHS
England (2020a) about supporting people with IDs during the
COVID-19 pandemic.
These guidelines are subject to revision and the most recent
versions can be downloaded by visiting http://radiant.nhs.uk.
The aim of this study is to describe our guidelines which focus
upon providing care and support before and after infection with
SARS-CoV-2 and the development of COVID-19. These guide-
lines are meant for community teams, inclusive of social care
providers, who provide care and treatment within community-
based settings and care teams working within hospital settings
for people with IDs. We have also included guidance about
referral and admission to general hospital. Community teams
providing care to people with IDs in England are referred to as
community learning disabilities teams and we use this language
in several places within this study. These teams provide a range
of care and support to people with IDs, while during the current
pandemic there will be an increased focus upon providing
TABLE 1 Group at risk because they are clinically vulnerable
due to severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2) infection who need particularly stringent social
distancing measures
• Aged 70 or older (regardless of medical conditions)
• Under 70 with an underlying health condition listed below
(that is, anyone instructed to get a flu injection as an adult
each year on medical grounds):
• Chronic (long-term) mild-to-moderate respiratory diseases,
such as asthma, chronic obstructive pulmonary disease
(COPD), emphysema or bronchitis.
• Chronic heart disease, such as heart failure.
• Chronic kidney disease.
• Chronic liver disease, such as hepatitis.
• Chronic neurological conditions, such as Parkinson’s disease,
motor neurone disease, multiple sclerosis, or cerebral palsy.
• Diabetes.
• A weakened immune system as the result of conditions such
as HIV and AIDS, or medicines such as steroid tablets.
• Being seriously overweight (a body mass index (BMI) of 40
or above).
• Pregnant women.
• People with intellectual or other developmental disabilities
and one or more of the following conditions:
• Diagnosis of severe and enduring mental health problem or
multiple mental health diagnoses within the acute phase or
taking medication that requires close monitoring (e.g.,
clozapine).
• Increased likelihood of escalation or re-emergence of
challenging behavior that will severely reduce quality of life.
• Coexisting physical vulnerabilities including epilepsy,
dysphagia, bowel problems including constipation,
gastroesophageal reflux disease (GORD), sensory deficits, or
other serious physical conditions not named in the lists
above.
TABLE 2 Extremely clinically vulnerable group at very high
risk of severe illness due to severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) infection who require shielding
measures
• Solid organ transplant recipients.
• People with specific cancers.
• People with cancer who are undergoing active chemotherapy.
• People with lung cancer who are undergoing radical
radiotherapy.
• People with cancers of the blood or bone marrow such as
leukemia, lymphoma, or myeloma who are at any stage of
treatment.
• People having immunotherapy or other continuing antibody
treatments for cancer.
• People having other targeted cancer treatments which can
affect the immune system, such as protein kinase inhibitors
or poly-ADP ribose polymerase (PARP) inhibitors.
• People who have had bone marrow or stem cell transplants
in the last 6 months, or who are still taking
immunosuppression drugs.
• People with severe respiratory conditions including all cystic
fibrosis, severe asthma, and severe chronic obstructive
pulmonary disease (COPD).
• People with rare diseases and inborn errors of metabolism
that significantly increase the risk of infections (such as
severe combined immunodeficiency (SCID), homozygous
sickle cell).
• People on immunosuppression therapies sufficient to
significantly increase risk of infection.
• Women who are pregnant with significant heart disease,
congenital or acquired.
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healthcare. We recognize that healthcare systems for people
with IDs around the world vary, and while our focus is upon
England, it is hoped that these guidelines will be applicable to
health and social care settings for people with IDs in other
countries, and as appropriate, helpful for educational settings.
We completely welcome and invite groups to adapt these guide-
lines to fit effectively within their own local, regional or national
health and social care systems.
Guidance about Responding to and Reducing the Risk of
Infection
For people with IDs living in the community in England,
physical healthcare is provided by primary care services, inclu-
sive of their general practitioner. This also includes the vital and
important role of carers working within shared residential set-
tings where many people with IDs live. The role of community
learning disabilities teams is to provide input into healthcare
about specific vulnerabilities, highlighting disparity, and helping
to reduce the risk of infection.
However, for community learning disabilities teams, if they
make use of the ratings listed within Tables 1 and 2, many
people with IDs receiving care will be assigned to the at risk of
severe illness from COVID-19 category, and many will also be
assigned to the very high risk of severe illness from COVID-19
due to associated comorbidity. Appropriate action should be
taken to mitigate the risk of infection within community-based
settings, inclusive of residential settings. Staff working within
psychiatric inpatient settings should also identify individuals
with IDs who are at risk as detailed in Tables 1 and 2. A sum-
mary of our guidance and associated risk mitigation strategies
are found in Figure 1.
Risk Mitigation Strategies
Hospital passports. Ensure that people with IDs have an up
to date hospital passport or equivalent, depending on the local,
regional or national policy, which includes information from
the person themselves, and all those who know them well,
including their family and advocates. A hospital passport is a
document that is meant to support the provision of appropriate
healthcare to a person with an ID. It includes essential informa-
tion about the person inclusive of important medical informa-
tion, their activities, and things the person prefers or does not
Identify those with intellectual disabilities 
who are at risk of severe illness and very high 
risk of severe illness (Table 1a and 1b) and 
use appropriate risk mitigation strategies.  
Risk Mitigation Strategies
1. Create or update hospital passports. 
2. Contact your community learning disabilities team and use their
expertise.  
3. Create a COVID-19 care plan (Table 3). 
4. Include carers and family members at all stages, consulting and
working effectively with the individual. Make sure you have a
good understanding of the mental Capacity Act (2005); best 
interest discussions and decisions will be needed for those who
do not have capacity to make a specified decision.    
5. Make use of reasonable adjustments when sharing information 
to help increase understanding using helpful resources.
6. Review and update positive behaviour support plans.  
7. Review and monitor medication.  
8. Take appropriate action to socially distance or isolate according
to risk.   Balance decision making against risk of infection and 
risk of challenging behaviour and mental health symptoms.  It 
may be appropriate for community access to continue which 
may be modified.  
9. Have appropriate Do not Attempt Resuscitation or 
Cardiopulmonary Resuscitation discussions and make plans 
collaboratively.  
10. Develop and implement a Ceiling of Care/Treatment Escalation 
Plan and share appropriately (Table 4). 
11. Liaise with local palliative care teams for support when needed.
12. Familiarise yourself with the Gold Standards Framework.  
13. Adjust communication when using personal protective 
equipment (slow down, introduce yourself, use a positive tone, 
affix a photograph to your gown, avoid complex sentences). 
Suspected or confirmed infection 
1. Isolate.  Assess in a single occupancy room and 
wear personal protective equipment. 
2. Monitor for RED FLAGS (Table 5) 
3. Follow wishes of individual, and/or family and 
carers.  
4. Further clinical decision making about transfer to 
hospital.  
5. Continue to make use of appropriate risk 
mitigation strategies.  
FIGURE 1 A summary of steps to take to mitigate risk and protect people who have intellectual disabilities during the COVID-19
pandemic.
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prefer. Ensure appropriate attention has been paid to the pres-
ence of physical health problems, including those which may
increase the risk of more severe illness due to contracting SARS-
CoV-2 (e.g., smoking history, history of heart disease, respira-
tory problems, body mass index (BMI) >40) and other condi-
tions such as mental health problems, dysphagia, sensory
problems, or communication needs. More information can be
found about hospital passports by visiting the Mencap website
(https://www.mencap.org.uk/advice-and-support/health/health-
guides). All people with disabilities are entitled to reasonable
adjustments to the provision of healthcare under the Equality
Act (2010), and a hospital passport is an example of a reason-
able adjustment. Further details about additional reasonable
adjustments should be included within the hospital passport.
COVID-19 care plan. Prepare a COVID-19 care plan for
each person with an ID within your care and this should be
developed collaboratively with the person. This should set out
the specific risk factors and associated needs of each individual
(Table 3) and community learning disabilities teams should
work collaboratively with care providers within residential set-
tings, bearing in mind that some people with IDs live alone and
may not have regular and consistent support beyond that pro-
vided by the community learning disabilities team. The care
plan should include information from the person (if appropri-
ate) and those who know the person well and refer to the hospi-
tal passport and incorporate relevant information. Issues
associated with diagnostic overshadowing, the views of parents,
family members and carers, the required reasonable adjust-
ments, communication needs, specialist mental health support,
anticipatory care plans, any end-of-life or do not attempt car-
diopulmonary resuscitation (DNACPR) discussions should be
reported. Associated strategies for managing hand hygiene,
infection control, social distancing, and isolation when needed
should be included.
Families and Carers. Carers and family members are vital to
the health and security of people with IDs (Chester, James, Rog-
ers, Grace, & Alexander, 2020), and more so during the
COVID-19 pandemic and should be involved at all stages. Clini-
cians should actively seek to explain the important precautions
that need to be taken with handwashing, avoiding touching the
face and eyes, use of tissues while coughing and sneezing and
their appropriate disposal to carers and people with IDs. It must
be recognized that this is not likely to be straightforward with
those who have severe and profound IDs. Limitations on access
to the community need to be explained. For those living within
residential settings, appropriate precautions and protocols need
to be developed for isolation should someone contract COVID-
19. There are a number of resources that can be used by carers
and families to help explain these challenges to people with IDs
(e.g., Beyond Words, 2020) while emphasizing the need to mon-
itor for signs and symptoms of COVID-19 including a fever,
new cough, fatigue, congestion, shortness of or difficulty breath-
ing, chill, muscle pain, dizziness, sore throat, headache,
vomiting, and diarrhea. Many people with IDs will have difficul-
ties explaining how they are feeling, and it is important that
family and carers remain vigilant to changes in presentation.
For example, many people with IDs may not be able to report
that they have a headache, while other symptoms are observable
to others (e.g., a new cough) and tools such as the Distress and
Discomfort Assessment Tool (https://www.stoswaldsuk.org/
how-we-help/we-educate/education/resources/disability-
distress-assessment-tool-disdat/) can be employed by carers to
record symptoms of distress (Regnard et al., 2007).
Capacity and law. Within England, where questions of
capacity arise regarding an individual’s ability to make a deci-
sion to isolate and take appropriate action to reduce risk
(e.g., social distancing), this may trigger an assessment of
capacity (The Mental Capacity Act, 2005) for some individ-
uals, bearing in mind that we will all make the assumption that
all have capacity to make decisions unless there is information
to the contrary. Appropriate reasonable adjustments
(e.g., sharing accessible information and providing clear expla-
nations with opportunities for individuals to ask questions)
should be made when sharing and discussing information. For
those who have capacity, they are entitled to make their own
decisions, and this may involve not following recommenda-
tions or advice which may cause them or others harm. For
those who are judged not to have capacity, this will prompt a
Best Interest discussion and may lead to an authorization of
Deprivation of Liberty for some. For such to be authorized in
relation to COVID-19, the person must lack capacity to con-
sent to the arrangements, have an “impairment of their brain
or mind” and the arrangements must be necessary to prevent
harm and be proportionate to the likelihood and seriousness
of the said harm. All of this would need to be balanced against
a person’s rights, autonomy, and well-being, and for many, this
could be avoided with the provision of good communication
and the involvement of carers and family members which is
strongly recommended. Related, and within England, The
Health Protection (Coronavirus, Restrictions) (England) Regu-
lations (Public Health England, 2020e) are relevant, which are
statutory restrictions on every person which prevent people
from leaving their homes without a “reasonable excuse.” The
police have been granted the powers of reasonable force to
return someone to their home. Furthermore, The Coronavirus
Act (2020) has made it a criminal offense to fail to comply
with the instructions of the police or a public health officer,
and the police may use reasonable force to remove people or
compel someone to remain at home. These laws are applicable
to all citizens, but their interface and relationship with the
Mental Capacity Act (2005) is unclear.
There are clear issues for many people who provide care to
people with IDs where routine and structure are exceptionally
important. Increasing isolation to protect people from infection
is likely to have a negative impact upon the quality of life of
people with IDs and may lead to an increase or re-emergence of
challenging behavior or the development of mental health prob-
lems. If individuals access the community, which will include
opportunities to visit places to engage in exercise and activities,
some individuals may require multiple support staff to be pre-
sent. This may attract the attention of other members of the
public and/or the police. Avoiding these activities is likely to be
detrimental to the health and well-being of many people with
IDs, disrupting their quality of life. Protecting individuals from
infection while maximizing quality of life is a tricky balancing
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act that must be navigated. Community learning disabilities
teams should work with families, and where necessary, consider
issuing letters to families, and carers that can be shown to the
police or public health officials as appropriate.
Social distancing. For all people with IDs, stringent social
distancing should be followed. This includes avoiding public
transport, remaining at home, and of course, avoiding contact
with those who have contracted SARS-CoV-2, or those who are
displaying symptoms of infection. For those who are judged to
be at very high risk of illness, shielding measures must be
adopted. This includes strictly avoiding contact with anyone dis-
playing symptoms, remaining at home, never attending gather-
ings, avoiding going out to shops or taking part in leisure
activities, arranging for food and medication to be delivered,
and where possible, making use of technology for social contact
as best as possible (Public Health England, 2020f). For carers
and those working in residential settings, Public Health England
has issued separate guidance which includes reducing visits
from family and friends. Individuals should be risk assessed,
and where possible, reasonable adjustments made. Staff should
wear personal protective equipment (PPE), and ensure proper
hand and environment hygiene (Public Health England, 2020b).
Changes to routine (e.g., canceling community trips) for people
with IDs may result in the development of, or an increase in
challenging behavior, and care plans and associated risk assess-
ment should be inclusive of these issues. In such instances, it is
reasonable to facilitate and support community trips in order to
reduce or escape a risk of harm, and in certain circumstances,
with careful planning to mitigate risk of infection, it may be
advantageous to facilitate some appropriate community trips for
people with IDs. This should be carefully considered, balancing
risk, and should be fully discussed with family members and
carers, as well as the community learning disabilities team.
Visits by community learning disabilities teams. As far as
possible, community learning disabilities teams should make
use of telephones and videoconferencing to contact carers,
family members and people with IDs. Team members, when
visits are necessary, should enquire as to whether anyone
within a property is displaying symptoms of COVID-19, and
make use of alternatives where such symptoms are present. If a
visit is needed, appropriate risk mitigation strategies should be
taken, and this may include wearing PPE during the visit. As a
minimum, a fluid resistant surgical mask, disposable apron,
and if blood or bodily fluid contamination is anticipated,
gloves and eye protection should be worn (Public Health
England, 2020a). Guidance changes rapidly and readers are
directed to follow the advice from their own regional or
national authority. Community visits are unlikely to involve
aerosol generation procedures, noting that spitting is not con-
sidered an aerosol generating procedure. If aerosol generation
procedures are likely, then an appropriate respirator, long-
sleeved disposable fluid-repellent gown, gloves, and eye protec-
tion must be work. Note that in situations where cardiopulmo-
nary resuscitation attempts and the use of suction are likely,
the continuous positive airway pressure and the use of high
flow nasal oxygen are aerosol generating procedures.
TABLE 3 Example brief COVID-19 care plan
Patient name, gender, date of birth: AB, male, January 01, 1965
1. Mr AB is a 55-year-old Caucasian male who is in supported
living.
2. Information about family and those who know the person well.
3. Diagnosis (mental health): mild intellectual disability, autistic
spectrum disorder, paranoid schizophrenia.
4. Diagnosis (physical health): bronchial asthma and early
chronic obstructive pulmonary disease (COPD), no
hospitalizations for that, not on regular inhalers. He is an
ex-smoker who is off cigarettes for over 5 years. He has
obesity with a body mass index (BMI) of 31 (he is not
morbidly obese).
5. His current medication is depot olanzapine and tab
procyclidine. He is on PRN salbutamol inhalers that he
usually does not like taking.
6. He is in supported living and has 24-hour staff support. At
present, though not keen on exercise he has no active physical
health symptoms. He carries out his daily activities with little
help from others.Actions: Information shared with GP
1. Mr AB is rated as a high-risk/vulnerable patient. This is firstly
because he has a mild learning disability, bronchial asthma and
early COPD, all conditions that come within the category of
the group at risk of severe illness from COVID-19. Secondly,
he is also considered to be vulnerable to having mental health
distress and relapse of his mental illness.
2. The Community Learning Disabilities Team (CLDT) has
given him and the staff in his home the following support:
a. Mental health: medication advice and associated information.
b. Mental health: updated psychological formulation and
behavior support plans.
c. Advice on a structured timetable of activities.
d. Advice on social distancing and other COVID-related
precautions (e.g., hand washing, infection control, isolation).
e. Advice from hospital passport (note legal requirement for
reasonable adjustments).
f. Advice from communication passport (note legal
requirement for reasonable adjustments).
g. Any other issues as relevant including information from the
hospital passport, views of parents and carers, need for
reasonable adjustments, behavioral responses to illness, and
specialist mental health or behavioral support.
h. Capacity: He appears to have the capacity to understand this
information. His capacity about treatment decisions, should
he become physically unwell, will need to be taken by the
treating clinician at that time.
i. End of life: any end of life or do not attempt
cardiopulmonary resuscitation (DNACPR) discussions or
decisions that have happened. Intellectual disabilities are not
to be used as a reason for authorizing DNACPR.For any
additional information from the CLDT, contact “name,
address, and telephone number.”
The above is a representative example and should be adapted as needed.
Journal of Policy and Practice in Intellectual Disabilities
Alexander R et al. • COVID-19
6
Do not attempt resuscitation or cardiopulmonary
resuscitation. These discussion and decisions are difficult for
all people, and the vast majority of people with IDs known to
community learning disabilities teams live full and rewarding
lives. Hence, end-of-life of DNAR or DNACPR discussions and
decisions are not necessary, but they may arise on some occa-
sions. It is important to note that IDs or Down syndrome
should never be used as a reason for issuing a DNACPR order
(NHS England, 2020b). Those who are ageing and have mul-
timorbidity who may suffer a marked deterioration in adaptive
behaviors may suffer a precipitous decline in their physical
health if they develop a virulent infection (Remuzzi &
Remuzzi, 2020; Zhou et al., 2020). In the context of the current
pandemic, while such discussions and decisions are likely to be
disturbing for many individuals, and families and carers, care-
fully formulated care plans for some are likely to be required.
When used appropriately, such plans are intended to reduce
suffering and promote a dignified death with those who are
close to the end of their life (National End of Life Care
Programme, 2011). The role of the community learning disabil-
ities team is not necessarily to oversee creating these plans, but
to work closely with the individual, their family, carers, and
those in primary care to help facilitate discussions as needed
within the context of the COVID-19 pandemic. The underlying
principles for any such discussion are set out by the National
End of Life Care Programme (2011) and should ensure that care
is client-centered and integrated, a circle of support is identified,
people are treated with dignity and respect, their preferences are
identified and respected, and appropriate care and support for
families, carers, and staff are provided after death.
Timely and honest conversations about an individual’s pref-
erences and priorities, including any advance decisions to refuse
treatment should be part of the care planning for anyone who
has a progressive life-limiting illness. The Care Quality Com-
mission (2016) has reported that the barriers to effective pallia-
tive and end-of-life care include a nonrecognition of end-of-life,
poor communication, inequalities in accessing good care, and
difficulties with staff awareness and noncollaborative working.
For most people with IDs who contract SARS-CoV-2, the prior-
ity will be treatment in line with national policies and guidance
including referral to general hospital as needed, and clinical
decision making should be the same as for members of the gen-
eral population, drawing on the same parameters. However, for
some, COVID-19 may quickly exacerbate existing illness and
create a situation where an individual may become very ill and
unable to benefit from intrusive treatment (Guan et al., 2020;
Huang et al., 2020; Richardson et al., 2020). Considering this,
honest conversations need to occur as early as practicable so
that personalized care and support plans can be developed.
These will need to be revisited if any situation changes, and
families and those close to an individual should be involved in
these discussions in line with a person’s wishes where possible.
There are several steps that services need to take which will
vary according to national policy and legislation. First, within
England, where there are concerns about capacity to make deci-
sions about medical treatment, a best interest discussion and
decision should happen, fully inclusive of family members and
carers and any attorney appointed under a Lasting Power of
Attorney or Enduring Power of Attorney if applicable, or
Personal Welfare Deputy. If a person has capacity to make deci-
sions about their medical treatment, then it is their decision to
refuse or accept treatment.
Second, a conversation should be started with and about
those who are nearing the end of their life. This should include
family members, carers, and others involved in the lives and
care of individuals with IDs. It should be recognized that this is
an area fraught with difficulty for people with IDs who may not
be appropriately included within decision making (Voss
et al., 2017). Advance care planning is something that is used to
help make decisions in the future, and this process is not just
about palliative care, but for any planning. The process should
help make clear a person’s wishes and will usually take place
within the context of an anticipated deterioration of a person’s
illness or condition in the future when they may have lost
capacity to make decisions. It is important that these decisions
are done sensitively and with empathy, and it is recommended
that community learning disabilities teams (or inpatient teams)
identify appropriate staff members for these conversations with
both the individual and their family. Staff should make use of
resources to help structure and support any conversations with
individuals (e.g., Books Beyond Words) to help make sure that
information is understood. Make sure that a holistic assessment
of end-of-life needs and preferences has taken place in partner-
ship with the individualand their families and carers. Assess and
respond sensitively to social, psychological, and spiritual needs
and wishes of the individual, as well as their physical healthcare
needs. Identify and record any further wishes and preferences as
they become apparent about future care and treatment and ver-
ify with the local general practitioner as needed. If appropriate
and requested, and for those who have capacity, you should
support someone to make an Advance Decision to Refuse Treat-
ment, sometimes referred to as a living will, and communicate
this to all those involved in the provision of care. Within
England, an Advance Decision is legally binding, and the indi-
vidual must name the treatments they are deciding to refuse
such as ventilation or cardiopulmonary resuscitation and the
circumstances in which they would be refused. An Advance
Decision to Refuse Treatment is not the same as an Advance
Statement. An Advance Statement can cover any aspect of
future health and social care and an individual must have capac-
ity to make decisions pertaining to the statement. It is not
legally binding, but those providing health and social care must
take it into account when making decisions.
Ceiling of care/treatment escalation plan
Third, a ceiling of care/treatment escalation plan should be
developed to document care planning. The purpose of this plan
is to identify the wishes of the individual, their families and their
carers in the case of a deterioration of physical health due to
developing COVID-19. It is to provide guidance to the attend-
ing clinicians and should not replace clinical judgment. Some
individuals may already have an Advance Statement, Advance
Decision to Refuse Treatment or Power of Attorney to advise
and make healthcare decisions. These should be followed
instead unless the clinical situation is markedly different to any
envisaged by the Advance Statement. An example of the issues
that should be covered when developing a ceiling of care/treat-
ment escalation plan is found in Table 4. Ideally, this should be
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completed with the individual, families, carers, and clinical and
social care staff, and it is vital that all are consulted and included
and consideration should be given to future transfer to general
hospital. During the pandemic, videoconferencing or teleconfer-
encing could be used to facilitate discussion and meetings. Once
a care plan has been completed, it should be shared with all staff
caring for the individual, and in the case of deterioration, on call
medical staff, out-of-hours general practitioners, or the para-
medic crew should be made aware. Any decision to transfer an
individual to hospital should be discussed with the family as
soon as possible and a copy of the ceiling of care/treatment esca-
lation plan should be sent, along with a covering letter if
helpful.
Fourth, learning disability teams need to liaise with local
Palliative Care Teams for support. As end-of-life approaches,
this should be recognized, and symptoms documented and dis-
cussed by the clinical team. Staff should consider any recent
changes in circumstances and note any new triggers in addition
to SARS-CoV-2 infection (e.g., worsening pre-existing physical
or mental illness). Staff will need to identify whether it is appro-
priate to begin an open and supportive discussion with the indi-
vidual, if possible, and their family and relatives about their
wishes for end-of-life care, bearing in mind whether the individ-
ual wishes to have open discussions about prognosis and future
care options. During the current pandemic, this may occur
using videoconferencing or teleconferencing which may lead to
some additional distress as relatives will not be able to be physi-
cally near their loved one.
Fifth, many general practitioners are likely to have
implemented an end-of-life care register specifically in relation
to COVID-19, working within the Gold Standards Framework
(see https://goldstandardsframework.org.uk/) and care must be
coordinated across health and social care systems, drawing upon
generic community nursing teams who deliver end-of-life care
in conjunction with specialist palliative care teams. NHS
England (2017) has published guidance about providing good
quality healthcare to people with IDs at the end of their life.
This includes ensuring that each person is seen as an individual,
helping them to develop an awareness of death and dying, while
involving families, carers, supporters, and friends. Clear com-
munication needs to occur between all care systems ensuring
that documentation is up to date, and bereavement support is
available for those left behind. Everyone should work to maxi-
mize comfort and wellbeing which includes helping people to
understand their illness to help reduce fear and encourage cop-
ing. This includes working to help people understand why treat-
ment is necessary and using creative methods to help encourage
understanding and coping. Related, it is important to complete
effective person-centered pain assessment.
Finally, during the last days of life it is important to be aware
that an individual’s condition could improve. Open discussions
will be required with families, friends, and carers, and where
possible adhere to patient wishes and preferences where needed,
ensuring that anticipatory prescribing systems are in place, or
there is a rapid system to access necessary medication. Antici-
pate and help plan for any specific religious, spiritual, or cultural
needs that may be necessary, helpful, and beneficial to both an
individual and their family. After death, it is important to be
respectful of religious, spiritual or cultural needs and beliefs and
that they are met. Teams need to be aware of verification and
certification of death policies. Ensure that appropriate informa-
tion is provided to family members and carers about what to do
after death, and offer support and information about bereave-
ment, and assist as appropriate with remembrance. Some of
these activities will have to occur over the telephone or via vid-
eoconferencing during the pandemic.
Mental health and challenging behavior. The current
restrictions upon all our lives have changed the way we live,
work, and interact with each other. These changes are likely to
cause distress for many people with IDs which are likely to lead
to an increase in challenging behaviors and mental health
TABLE 4 Topics to be included within a ceiling of care/
treatment escalation plan
1. Name, date of birth, address.
2. Information about whether there is an existing current
advance plan, such as an Advance statement, advance
decision of refusal of treatment, or lasting power of attorney
for health/welfare or deputy.
3. Details pertaining to an assessment of mental capacity.
Remember that this is decision specific, and capacity is
assumed as the default position.
4. Record any discussions with individuals, their family
members, carers, friends, and others.
5. Record any decisions about cardiopulmonary resuscitation. If
a decision is made to not attempt cardiopulmonary
resuscitation, then a do not attempt resuscitation or
cardiopulmonary resuscitation form must be completed.
6. Record information about the ceiling of care. This could be
Full Active Care which would be transfer to general hospital,
or Palliative/End of Life Care which would not be transfer to
the general hospital and input from palliative care services
would be needed working with generic community nursing
teams who provide end-of-life care. Some community-based
residential services are not equipped to provide a full range
of palliative care services which may necessitate transfer to
hospital or a palliative care unit, especially if there is
treatment available which significantly improves pain,
discomfort or dignity. This could also be Care within an
Existing Inpatient Psychiatric Ward environment if that is
where the individual is currently located. This would not
involve transfer to a general hospital unless there is
treatment which would significantly improve pain,
discomfort or dignity which cannot be provided within the
psychiatric hospital.
7. Include information about prescribing antibiotics including
whether they require oral only, and whether intravenous
antibiotics may be appropriate, or no further antibiotics are
to be given (unless required for symptom control).
8. Food and fluids including whether intravenous fluids are not
appropriate, or a percutaneous endoscopic gastrostomy tube
is appropriate. Consider wider issues about inability to
swallow and whether this is part of the progression of the
disease.
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symptoms. It is entirely likely that when an individual with IDs
is faced with actual or suspected SARS-CoV-2 infection, the
inevitable further restrictions may lead to a worsening of mental
health symptoms and/or challenging behavior. It is important
not to assume that this is inherently a relapse of mental illness,
as some changes occur directly as a result of environmental
changes, or could be associated with SARS-CoV-2 infection and
unknown effects on the nervous system (Wu et al., 2020), and
issues related to diagnostic overshadowing should be at the fore-
front of clinical decision making. It is important to carefully
monitor behavior and mental state, including the use of any
restrictive interventions that are used within home and residen-
tial settings. Community learning disabilities teams have an
important role to play in maintaining community living and
preventing inappropriate admission to psychiatric inpatient set-
tings and should always be consulted and included. Community
learning disabilities teams have an important proactive role to
play by providing advice on behavior and supporting people
within the home, and the Challenging Behaviour Founda-
tion (2020a, 2020b) has produced some helpful guidance that
may assist families and carers. Wider guidance is available from
other organizations (e.g., British Psychological Society: https://
www.bps.org.uk/responding-coronavirus). Other resources from
around the world have been posted online by the International
Association for the Scientific Study of Intellectual and Develop-
mental Disabilities (2020). If needed, training and advice to
home and residential settings can be delivered using videocon-
ferencing. We are recommending that those with IDs who have
severe and enduring mental health problems, inclusive of but
not limited to schizophrenia, psychosis and bipolar disorder,
and those with multiple mental health diagnoses, or who are
taking medication that requires close monitoring
(e.g., clozapine), along with those who are likely to experience
an increase or reemergence of challenging behaviors that will
severely impair their quality of life are rated as high risk of
severe illness due to SARS-CoV-2 infection (Table 1). These two
additional groups have been added to Table 1.
A variety of changes are likely to lead to an increase in emo-
tional distress during the COVID-19 pandemic and community
learning disabilities teams will need to work effectively with
individuals with IDs, their carers and families and providers of
community-based services to help mitigate distress. Changes to
routine may cause increased anxiety, which may lead to an
increase in challenging behavior and mental health symptoms.
Many of these challenges are likely to be related to difficulties
with effective communication and understanding the changes,
mental health problems, and other associated functions such as
demand avoidance, access to tangibles inclusive of previously
enjoyed activities. Behavioral support plans, such as the positive
behavioral support plan will need to be revised accordingly and
there is an important role for the specialist advice and support
of the community learning disabilities team. This would include
an updated formulation as needed, along with the provision of
psychological and other associated interventions to help with
challenging behavior and mental health. Changes to key staff
including carers, community learning disabilities team mem-
bers, parents and family members (who may be absent due to
isolation and illness) may cause further anxiety and disruption
and will need to be effectively managed, and may have a
negative impact upon the continued successful implementation
of positive behavioral support plans. Further training may be
needed, which could be delivered online by community learning
disabilities teams as needed. For some, family members and
carers may be admitted to hospital due to COVID-19 which
may result in the loss of life and will cause associated bereave-
ment and grief for many people with IDs, and appropriate strat-
egies should be incorporated into a positive behavior support
plan. For those family members who become unwell, it is
important for services to facilitate ongoing contact using elec-
tronic methods of communication. Most importantly, services
must recognize the importance of normal human emotional
expression during times of stress, and this should not be pathol-
ogized. People with IDs may require additional help and sup-
port to understand what is happening to successfully grieve
during a time when they may not be afforded the opportunities
to grieve in a traditional manner (e.g., attending a funeral, seek-
ing comfort from loved ones and family members). There is a
clear role for specialist psychological interventions delivered by
community learning disabilities teams.
Personal protective equipment
The use of PPE is likely to have a substantial impact upon
some people with IDs as follows: (a) it will disrupt some non-
verbal communication as facial expressions will be entirely or
partially covered which are vital to good communication. In
such circumstances, eyes and natural gesture should be used as
much as possible to facilitate positive communication,
(b) equipment which covers the mouth may change speech,
making intelligibility problematic, and (c) equipment may pro-
voke anxiety among some individuals which may change the
nature and quality of the interaction. It is important that staff
wearing PPE introduce themselves, continue to adopt a positive
tone, and use the name of the person within the interaction. It
is likely to be advantageous to add a photograph of a staff mem-
ber’s protective clothing to help with identification. Speech
should be slowed down as appropriate, but not condescending,
and if needed, increase the volume of speech and allow individ-
uals time to process communication. Sentences should be as
clear as possible, incorporating a single piece of information;
complex and long sentences with multiple conjunctions and
connectives should be avoided. If helpful, use can be made of
writing or drawing to aid communication, and checks made to
ensure that communication has been understood. It is also
important for all healthcare staff to recognize that many people
with severe to profound IDs may make use of signing or
symbol-based communication, and those who know individuals
(usually the family members and carers) well are best placed to
provide guidance and support. People with IDs are entitled to
reasonable adjustments when accessing healthcare in England,
and similar requirements exist in other jurisdictions around the
world.
Psychotropic medication
It is vital that psychotropic medications are reviewed appro-
priately in line with good practice guidance (e.g., NICE, 2016).
It is important to pay attention to side effects such as respiratory
depression and cardiac effects. This would mean carefully ana-
lyzing the effects and side effects and weighing this against the
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importance of maintaining good mental health. Be aware of
issues associated with diagnostic overshadowing (e.g., a high
fever may be a rare side effect called neuroleptic malignant syn-
drome or serotonin syndrome rather than due to COVID-19).
Close liaison with pharmacy services will be needed to make
sure that required medications are available, and medications
may have to be delivered by healthcare staff or via the post.
Changes to medication may be required to assist in the manage-
ment of mental health symptoms, and some individuals may
require depot medication which is administered by general
practitioners, community nurses within community learning
disabilities or mental health teams.
Guidance Regarding Care and Support Following Infection
or Suspected Infection
For many people with IDs who are infected with SARS-
CoV-2, they will receive care at home, and many will recover
while others will not develop COVID-19. However, some will
need to be transferred to a general hospital, and when admitted,
we recommend that the community learning disabilities team
works closely with those in hospital to ensure a robust handover
of relevant information and assist with decision making. This
work may take place through liaison teams for mental health
and/or IDs where they are available within the general hospital,
inclusive of the valued role of specialist liaison nurses for people
with IDs who will be able to provide specialist assistance with
the provision of reasonable adjustments within a general hospi-
tal setting (MacArthur et al., 2015). For those who are currently
detained within psychiatric settings, the treating team will have
responsibility for both physical and mental healthcare.
Suspected SARS-CoV-2 Infection
Individuals should be assessed within a single occupancy
room, and the clinician should wear PPE for all face-to-face
interactions regardless as to whether SARS-CoV-2 infection is
suspected. As a minimum, this should be a fluid resistant surgi-
cal mask, single-use disposable apron, gloves, and eye protection
if blood or bodily fluid contamination to the eyes or face is
anticipated. If aerosol generation procedures are likely, then an
appropriate respirator mask, long-sleeved disposable fluid-
repellent gown, gloves, and eye protection must be worn. Note
that in situations where cardiopulmonary resuscitation
attempts, and the use of suction are likely, continuous positive
airway pressure and the use of high flow nasal oxygen are aero-
sol generating procedures.
It is important that staff explain their policy about isolation
to all individuals within the hospital should there be suspected
SARS-CoV-2 infection. This should include the specific details
as to what will happen and when. Appropriate communication
aids may need to be used, and staff experienced in working with
people with IDs should be called upon as they will be acutely
aware of individual communication needs. Teams need to work
effectively to minimize the need for restrictive interventions to
implement isolation procedures through effective communica-
tion and the continued maintenance of trusted therapeutic
relationships. Isolation is likely to be distressing and leads to an
increase in challenging behavior and the use of PPE may cause
distress and appropriate action should be taken to mitigate this
distress as outlined in the previous section.
Services should make use of provided SARS-CoV-2 testing
kits and send swabs to the designated site for testing. Anyone
who has reported symptoms should be isolated for the number
of days required by local or national policies, and physical mon-
itoring must continue. Ensure adequate nutrition and hydration,
and symptomatic treatment as appropriate (e.g., paracetamol
for fever, asthma medication as indicated, maintain fluid intake,
complete urine output charts, etc.). Watch for any signs of dete-
rioration; fever can continue for a few days, but respiratory
function may worsen between 5 and 12 days. Action must be
taken if any of the red flags are present as listed in Table 5 as
adapted from Greenhalgh et al. (2020). When present, these
symptoms indicate that urgent assessment is needed and further
action such as escalation to an acute hospital or ongoing asser-
tive management of health is needed. Note that COVID-
19-related pneumonia may be complicated by respiratory dis-
tress, and there are additional risks associated with dysphagia,
and consistent regular physical health monitoring using stan-
dardized and validated instruments should be used
(e.g., National Early Warning Score-2; Royal College of
Physicians, 2017).
Public Health England (2020c) has provided guidance on
when to transfer someone to a general hospital, inclusive of
those within psychiatric settings. Transfer to a general hospital
should occur when: (1) they have clinical or radiological evi-
dence of pneumonia, or (2) acute respiratory distress syndrome,
or (3) they have influenza like illness. This is a fever ≥37.8C
TABLE 5 COVID-19 Red Flags for people with intellectual
disabilities adapted from Greenhalgh, Koh, and Car (2020)
1. Severe shortness of breath at rest
2. Difficulty breathing
3. Pain or pressure in the chest (may clutch at the chest or
show obvious signs of distress)
4. Onset of new confusion or worsening of challenging
behavior
5. Becoming difficult to rouse
6. Not eating or drinking
7. Little or no urine output
8. Cold clammy or pale mottled skin
9. Blue lips
10. Coughing up blood
11. Neck stiffness
12. Non blanching skin rash
13. Heart rate >100 with new confusion/challenging behavior
14. Respiratory rate >20
15. Oxygen SATS ≤94%
16. Temperature >38If in doubt discuss with a physician as
per local arrangements.
The Distress and Discomfort Assessment Tool AT tool (Regnard
et al., 2007) can be used to monitor pain and distress and use of an instru-
ment like National Early Warning Score (Royal College of Physicians, 2017)
is recommended to monitor physical health.
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and at least one of the following respiratory symptoms with
acute onset: (1) persistent cough (with or without sputum),
(2) hoarseness, (3) nasal discharge, (4) shortness of breath,
(5) sore throat, (6) wheezing, or (7) sneezing. Clinicians should
test for SARS-CoV-2 when an individual is presenting with new
respiratory symptoms or fever without another cause or worsen-
ing of a pre-existing respiratory condition. Early recognition of
a deteriorating individual and referral to a general hospital is
critical for treatment as patients may present with sepsis, pneu-
monia, and adult respiratory distress syndrome. Those with
underlying health conditions as set out in Tables 1 and 2 are
likely to progress to a complicated illness. There are important
discussions that need to take place between staff within residen-
tial care settings, or psychiatric hospitals, and the general hospi-
tal and issues to be covered are presented in Table 6.
When transferring an individual to a general hospital, they
should be accompanied by at least one member of staff who
knows them well, taking their hospital passport and COVID-19
care plan. Staff should be supported with this task, as they may
experience justifiable anxiety at the prospect of attending hospi-
tal, and can be reassured that if all the guidance is followed
(e.g., regular handwashing) and wearing the correct PPE, it is
safe for them to carry out escort duties. Within England, if
detained under the Mental Health Act (1983, as revised in 2007)
Section 17 leave must be authorized, and staff must always
remain with the individual. If the individual is transferred under
Section 19, then the general hospital must ensure that they have
adequate mental health staff to provide support, bearing in
mind it would be better to have staff with a pre-existing positive
relationship accompany them.
People Currently Detained with Psychiatric Hospitals
For many psychiatric hospitals, they will be providing care
directly to patients who develop COVID-19 during the
pandemic, and many of these patients will recover without
needing to be transferred to a general hospital. However, all
teams should continue to work towards the successful discharge
of individuals with IDs from psychiatric hospitals. Where possi-
ble and appropriate, it would be useful to expedite discharge
safely.
There are related concerns about some of the changes that
have been made to the provisions of the Mental Health
Act (1983, as revised in 2007) as a consequence of the Coro-
navirus Act (2020) in terms of the implications for people
with IDs. These changes include the removal of the require-
ment for two medical practitioners to agree to the detention
of an individual under Section 2, and many Sections of Part
III of the Mental Health Act, if arranging for two medical
practitioners is judged to be impractical or would cause delay.
Holding powers under Section 5 and Section 136 have been
increased in duration, and a Responsible Clinician has been
granted the authority to act as a Second Opinion Appointed
Doctor, again if securing a Second Opinion Appointed Doc-
tor is likely to be associated with unreasonable delay. There
are concerns that these changes may inadvertently lead to an
increase in the number of people with IDs detained under the
Mental Health Act (1983, as revised in 2007). It is our view
that these changes should not be used disproportionately to
detain people with IDs within psychiatric hospitals if
implemented, and community learning disabilities teams
need to work effectively with all authorities during the pan-
demic to continue to provide excellent care and support to
families to help guard against unnecessary admission to hos-
pital continuing to work within the spirit of the Transforming
Care (NHS England, 2017) Agenda in England.
Conclusions
The aim of this study was to present our initial guidelines
for the care and treatment of people with IDs during the
COVID-19 pandemic, developing best practice guidance. This
was prompted by concerns that people with IDs may be
afforded poor quality care during the COVID-19 pandemic, and
especially upon contracting SARS-CoV-2. In England, these
concerns were brought to the fore when the NICE (2020a) rec-
ommended using the Clinical Frailty Score to aid decisions
about treating individuals who have contracted SARS-CoV-2.
The guidance was rapidly revised to exclude the use of this score
with people with IDs. However, there remain concerns that
healthcare services will not prioritize the care of people with IDs
and some GP practices have actively stated that they will adopt
this course of action (Thomas, 2020).
We have developed our guidance with issues of disparity of
healthcare for people with IDs in mind. This is a group that has
marked comorbidity (Cooper et al., 2015; O’Leary et al., 2018),
and some will be at very high risk of severe illness due to SARS-
CoV-2 infection because of multi-morbidity. In the absence of
specific criteria for rating risk due to SARS-CoV-2 infection
among people with IDs specifically, we have opted to adapt the
risk criteria published by Public Health England (2020d, 2020f),
incorporating mental health and challenging behavior which is
prevalent among people with IDs and likely to impact upon the
TABLE 6 Points to be covered in a referral discussion to a
general hospital
1. Name of individual, age, and sex/gender.
2. Full diagnoses including physical and mental health
including any conditions listed within Tables 1 and 2.
3. Nature and duration of current symptoms and deterioration.
4. Functional ability, capacity and other relevant information
from existing COVID-19 care plan and health passport. Note
that clinicians have a responsibility to advocate for the
person with an intellectual disability (ID); they should not be
denied care because of disability.
5. If there are questions about instruments like the Clinical
Frailty Score, please be aware that the National Institute for
Health and Care Excellence has made it clear that this should
not be used with people with IDs when making decisions
about critical care. The same should apply to other
instruments which do not consider intellectual or other
developmental disabilities appropriately. The referrer should
help ensure that any assessment is individualized.
Journal of Policy and Practice in Intellectual Disabilities
Alexander R et al. • COVID-19
11
nature of course of contracting SARS-CoV-2 as there is a risk of
a relapse or increase in both mental health symptoms and/or
challenging behavior. There is no direct evidence currently that
SARS-CoV-2 infection will cause an increase in mental health
symptoms and/or challenging behavior at the moment, but the
associated changes that are occurring within our society and the
required treatments are likely to lead to distress and anxiety
among those with IDs. It is our view, at the current time, that
adapting the current guidance to include people with IDs who
have severe and enduring mental health problems or those who
have a substantial risk of an increase in challenging behavior is
a reasonable addition.
Community learning disabilities teams and inpatient psy-
chiatric hospitals have an important role in addressing dispar-
ity in general healthcare, collaboratively with families and
carers, for people with IDs. This role is vital as it will make
sure those who need help, get help, when and where it is
needed, in the way that it is needed. We should all continue to
work towards preventing admission to inpatient psychiatric
hospitals and continue to work to facilitate timely and appro-
priate discharge. Once the pandemic is over, we do not want to
be in a position of having an increased number of people with
IDs within psychiatric hospitals due to difficulties with manag-
ing risk associated with SARS-CoV-2 infection or community
access, or due to a deterioration in mental health or increase in
challenging behavior related to the COVID-19 pandemic. All
health and social care providers need to work together to
achieve this goal collaboratively, and community learning dis-
abilities teams, together with their hospital colleagues, are vital
providers of care and support.
We have explicitly outlined actions that need to be taken by
health and social care staff within both the community and
inpatient psychiatric settings to help organize and deliver care
to people with IDs, inclusive of their families and carers. This
includes the creation of a COVID-19 care plan for individuals
who are at very high risk, creating or updating hospital pass-
ports, improving psychological support and communication
through the revision of positive behavioral support plans as
needed, and the creation of a ceiling of care/treatment escalation
plan. The goal of the ceiling of care/treatment escalation plan is
to ensure that the wishes of individuals, families, and carers are
recorded and followed appropriately, helping to ensure disparity
is addressed. IDs are not fatal conditions and should never be
the basis for authorizing DNACPR. We recognize that many of
these conversations will be distressing for individuals with IDs,
their families and carers, and community and inpatient staff
who are experienced in providing care and treatment to people
with IDs are well placed to provide high quality support
and care.
Finally, we fully recognize that our guidance has been con-
textualized within English policy and law. Healthcare systems
around the world differ, and in some countries, there are no
specialist teams for people with IDs offering services within the
community, residential services or within inpatient psychiatric
services. However, we wish to strongly encourage others to take
our work and adapt it as needed to meet the needs of their own
local, regional, or national populations and to ensure that indi-
viduals with IDs exercise their human rights to appropriate
healthcare support.
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